Regulations Assessment Workgroup

At a glance

The Clinical Laboratory Improvement Amendments of 1988 (CLIA) Regulations Assessment Workgroup advises Clinical Laboratory Improvement Advisory Committee (CLIAC) for consideration in making recommendations to HHS on revising the CLIA regulations.

Overview

The CLIA Regulations Assessment Workgroup provides input to CLIAC. CLIAC deliberates on how the Department of Health and Human Services might update CLIA considering the:

  • April 2019 reports by the Personnel Regulations.
  • Non-Traditional Workflow Models.
  • NGS workgroups.
Keep Reading: Clinical Laboratory Improvement Amendments

Reports

Officers and members

Co-chairs

Kimberle C. Chapin, MD

Medical and Scientific Affairs
Cepheid

Gregory N. Sossaman, MD

System Chairman, Ochsner Health System
Department of Pathology and Laboratory Medicine
Ochsner Medical Center

Designated Federal Officer

Heather L. Stang, MS, MLS

Senior Advisor for Clinical Laboratories
Clinical Laboratory Improvement Advisory Committee Executive Secretary
Division of Laboratory Systems
Office of Laboratory Science and Safety
Centers for Disease Control and Prevention

Ex Officio Members

Sarah Bennett, MT(ASCP)

Technical Director
Division of Clinical Laboratory Improvement and Quality
Quality, Safety and Oversight Group
Centers for Clinical Standards and Quality
Centers for Medicare & Medicaid Services

Víctor R. De Jesús, PhD

Chief, Quality and Safety Systems Branch
Division of Laboratory Systems
Office of Laboratory Science and Safety
Centers for Disease Control and Prevention

Tamara Pinkney, MT(ASCP)

CLIA Program Lead/Policy Analyst
Division of Program Operations and Management
Office of In Vitro Diagnostics 
Center for Devices and Radiological Health
Food and Drug Administration

Print
Content Source:
Division of Laboratory Systems (DLS)